Package Leaflet: Information for the User
Duomate Flas 30mg Orodispersible Tablets
Lansoprazole
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
The active substance of Duomate Flas is lansoprazole, a proton pump inhibitor. Proton pump inhibitors reduce the amount of acid produced by the stomach.
Your doctor may prescribe you Duomate Flas for the following indications:
It may be that your doctor has prescribed Duomate Flas for another indication or at a different dose than indicated in this leaflet. Follow your doctor's instructions regarding the taking of the medicine.
Do not take Duomate Flas:
Warnings and precautions
When taking lansoprazole, kidney inflammation may occur. The signs and symptoms may include decreased urine volume or the presence of blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. You should inform your doctor of these signs.
Consult your doctor before starting to take Duomate Flas:
If you experience a skin rash, especially in areas of the skin exposed to the sun, consult your doctor as soon as possible, as it may be necessary to interrupt treatment with Duomate Flas. Remember to mention any other symptoms you may notice, such as joint pain.
Inform your doctor if you have a serious liver disease. It may be necessary for the doctor to adjust the dose.
Your doctor may have performed or may perform a complementary test called endoscopy to diagnose your disease and/or rule out cancer.
In case you experience diarrhea during treatment with Duomate Flas, contact your doctor immediately, as Duomate Flas has been associated with a slight increase in infectious diarrhea.
If your doctor has prescribed Duomate Flas in addition to other medicines intended for the treatment of Helicobacter pyloriinfection (antibiotics) or together with anti-inflammatory drugs to treat pain or rheumatism, also read the package leaflets of these medicines carefully.
If you are taking proton pump inhibitors like Duomate Flas, especially for a period of more than one year, you may have a slightly increased risk of hip, wrist, and spine fractures. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
If you have been taking Duomate Flas for more than three months, it is possible that your blood magnesium levels may decrease. Low magnesium levels can cause fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness, and increased heart rate. If you experience any of these symptoms, go to the doctor immediately. Low magnesium levels can also cause a decrease in blood potassium and calcium levels. Your doctor may decide to perform periodic blood tests to monitor magnesium levels.
If you have been taking Duomate Flas for a long time (more than 1 year), your doctor will probably have you checked regularly. During visits to your doctor, you should inform them of any new or abnormal symptoms and circumstances.
Using Duomate Flas with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
In particular, inform your doctor if you are using medicines that contain any of the following active substances, as Duomate Flas may affect their mode of action:
Taking Duomate Flas with food and drinks
To get the best results from your medicine, you should take Duomate Flas at least 30 minutes before meals.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Driving and using machines
Patients taking Duomate Flas may occasionally experience side effects such as dizziness, vertigo, fatigue, and visual disturbances. If you experience any of these side effects, you should act with caution as your reaction ability may be reduced.
You are the only person responsible for deciding whether you are fit to drive vehicles or perform activities that require a high level of concentration. Due to its effects or adverse reactions, one of the factors that can reduce your ability to perform these operations safely is the use of medicines.
In the following sections, you will find descriptions of these effects.
Read the information in this leaflet carefully.
If you have any further questions, ask your doctor, nurse, or pharmacist.
Duomate Flas contains sucrose.
If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Follow the instructions for administration of this medicine indicated by your doctor. In case of doubt, consult your doctor again.
Place the tablet on the tongue and suck it slowly. The tablet dissolves quickly in the mouth, releasing microgranules that should be swallowed without chewing.
You can also swallow the tablet whole with a glass of water.
Your doctor may give you instructions to administer the tablet through a syringe, in case you have serious difficulties swallowing.
Follow the following instructions in case of administration through a nasogastric tube (with a diameter of 12F or 18F):
Follow the following instructions in case of oral administration through a syringe:
It is important that you check that the selected syringe is suitable.
If you take Duomate Flas once a day, try to take it always at the same time. You may get better results if you take Duomate Flas in the morning.
If you take Duomate Flas twice a day, you should take the first dose in the morning and the second dose at night.
The dose of Duomate Flas depends on your general condition. The normal doses of Duomate Flas for adults are indicated below. Sometimes, your doctor may prescribe a different dose and indicate a different duration of treatment.
Treatment of heartburn and acid regurgitation:one 15 mg or 30 mg orodispersible tablet per day for 4 weeks. If symptoms persist, inform your doctor. If symptoms do not improve after 4 weeks, consult your doctor.
Treatment of duodenal ulcer:one 30 mg orodispersible tablet per day for 2 weeks.
Treatment of gastric ulcer:one 30 mg orodispersible tablet per day for 4 weeks.
Treatment of inflammation of the esophagus (reflux esophagitis):one 30 mg orodispersible tablet per day for 4 weeks.
Long-term prevention of reflux esophagitis:one 15 mg orodispersible tablet per day; your doctor may adjust the dose to one 30 mg orodispersible tablet per day.
Treatment of Helicobacter pyloriinfection:The normal dose is one 30 mg orodispersible tablet together with two different antibiotics in the morning and one 30 mg orodispersible tablet together with two different antibiotics in the evening. The normal treatment is once a day for 7 days.
The recommended combinations of antibiotics are as follows:
If you receive anti-infective treatment due to an ulcer, it is unlikely that the ulcer will recur if the infection is treated satisfactorily. To get the best results from your medicine, take it at the right time and do not miss any dose.
Treatment of duodenal or gastric ulcers in patients who require continuous treatment with NSAIDs: one 30 mg orodispersible tablet per day for 4 weeks.
Prevention of duodenal or gastric ulcers in patients who require continuous treatment with NSAIDs:one 15 mg orodispersible tablet per day; your doctor may adjust the dose to one 30 mg orodispersible tablet per day.
Zollinger-Ellison syndrome:The initial normal dose is two 30 mg orodispersible tablets per day; subsequently, based on your response to treatment with Duomate Flas, the doctor will decide the best dose for you.
Use in children
Duomate Flas should not be administered to children.
If you take more Duomate Flas than you should
If you take more Duomate Flas than you have been told, consult your doctor immediately or call the Toxicology Information Service. Phone 915 620 420.
If you forget to take Duomate Flas
If you forget to take a dose, take it as soon as you remember, unless the time for the next dose is near.
In this case, skip the missed dose and take the next orodispersible tablets as usual. Do not take a double dose to make up for the missed dose.
If you stop taking Duomate Flas
Do not stop treatment early because the symptoms have improved. It is possible that your condition has not been completely cured and may recur if you do not complete the entire treatment.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects are common (occur in more than 1 in 100 patients):
The following side effects are uncommon (occur in less than 1 in 100 patients):
The following side effects are rare (occur in less than 1 in 1,000 patients):
The following side effects are very rare (occur in less than 1 in 10,000 patients):
Frequency not known
If you notice side effects not mentioned in this leaflet or if you suffer from one of the side effects described in a severe way, inform your doctor or pharmacist.
If you experience side effects, consult your doctor, even if it is a side effect not listed in this leaflet.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to a pharmacy for disposal. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Duomate Flas Composition
Product Appearance and Packaging Content
Duomate Flas 15 mg are white-gray tablets containing microgranules.
Duomate Flas 15 mg is available in packs of 14, 28, or 56 tablets.
Marketing Authorization Holder and Manufacturer
LABORATORIOS SALVAT, S.A.
Gall 30-36
08950 Esplugues de Llobregat
Barcelona - Spain
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Duomate 15 mg compresse orodispersibili Italy
Date of Last Revision of this Leaflet:December 2022
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)
http://www.aemps.gob.es/